Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study-Reference-Cited by-同舟云学术

Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study

Published:2023-04 Issue:4 Volume:8 Page:e294-e304
ISSN:2468-2667
Container-title:The Lancet Public Health
language:en
Short-container-title:The Lancet Public Health

Author:

Isfordink Cas J,Boyd Anders,Sacks-Davis Rachel,van Santen Daniela K,Smit Colette,Martinello Marianne,Stoove Mark,Berenguer Juan,Wittkop Linda,Klein Marina B,Rauch Andri,Salmon Dominique,Lacombe Karine,Stewart Ashleigh,Schinkel Janke,Doyle Joseph S,Hellard Margaret,van der Valk Marc,Matthews Gail V

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health

Reference22 articles.

1. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis;Platt;Lancet Infect Dis,2016

2. Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients—French ANRS CO13 HEPAVIH cohort;Piroth;J Hepatol,2017

3. Moving towards hepatitis C micro-elimination among people living with human immunodeficiency virus in Australia: the CEASE study;Martinello;Clin Infect Dis,2020

4. High treatment uptake in human immunodeficiency virus/hepatitis C virus-coinfected patients after unrestricted access to direct-acting antivirals in the Netherlands;Boerekamps;Clin Infect Dis,2018

5. HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study;Smit;Lancet HIV,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019;International Journal of Drug Policy;2024-02

2. Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC);International Journal of Epidemiology;2023-12-08

3. Socio‐economic factors associated with loss to follow‐up among individuals with HCV: A Dutch nationwide cross‐sectional study;Liver International;2023-09-17

4. The road to hepatitis C virus elimination;The Lancet Public Health;2023-04